vimarsana.com
Home
Live Updates
New Comprehensive Phase 3 Data Show First-in-Class TREMFYA
New Comprehensive Phase 3 Data Show First-in-Class TREMFYA
New Comprehensive Phase 3 Data Show First-in-Class TREMFYA® (guselkumab) Provided Durable Improvements in Measures of Psoriatic Arthritis (PsA) Disease Activity Through Two Years
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced comprehensive efficacy and safety data from the DISCOVER–2 trial of...
Related Keywords
Langley ,
British Columbia ,
Canada ,
Japan ,
Spring House ,
United States ,
Horsham ,
Saskatchewan ,
American ,
Jennifer Mcintyre ,
Alyssa Johnsen ,
Donvitot Creakyjoints ,
Philip Mease ,
Bridget Kimmel ,
Zismand Comorbidities ,
Item Short Form Survey Physical Component Summary ,
American College Of Rheumatology ,
Janssen Research Development ,
Janssen Pharmaceutical Companies ,
Janssen Pharmaceutical Companies Of Johnson ,
University Of Washington School Medicine ,
National Psoriasis Foundation ,
Swedish Medical Center Providence St ,
Journal Of The American Academy Dermatology ,
None Of The Janssen Pharmaceutical Companies ,
Stanford Health Assessment Questionnaire ,
Joseph Health ,
Drug Administration ,
Health Assessment Questionnaire Disability Index ,
Arthritis Research Therapy ,
Exchange Commission ,
Companies Of Johnson ,
Group For Research ,
Rheumatology Research ,
Johnson ,
American College ,
Global Assessment ,
Swedish Medical ,
Clinical Professor ,
Washington School ,
Heijde Modified Sharp ,
Vice President ,
Rheumatology Disease Area Leader ,
Janssen Research ,
Psoriasis Area ,
Severity Index ,
Psoriatic Arthritis ,
Mental Component Score ,
Prescribing Information ,
Medication Guidefor ,
Pharmaceutical Companies ,
Infectious Diseases ,
Private Securities Litigation Reform Act ,
Annual Report ,
Note Regarding Forward Looking ,
Quarterly Report ,
Monoclonal Antibody Specific ,
Placebo Controlled Study Conducted ,
Active Psoriatic ,
Specific Monoclonal Antibody ,
Through One Year ,
Naive Patients With Psoriatic ,
Safety Results Through One Year ,
American Academy ,
Safety Results Of Two ,
Participants With Active Psoriatic Arthritis ,
Accessed October ,
Gone Prior ,
Guselkumab Administered Subcutaneously ,
Dermatological Treatment ,
Accessed Oct ,
Rheum Dis ,
Painful Arthritis Symptom You Should Know ,
Sausage Finger Swelling You Should Know ,
Rambam Maimonides Med ,
About Psoriatic ,
Immune Based Therapies ,
Study Evaluating ,
Janssen Pharmaceutical Companies Of Johnson Amp ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Pharmaceuticals ,
Clinical Trials Amp Medical Discoveries ,